Get the Stockscreener App
0.00
100.00%
-0.627
Lakeshore Biopharma Co Ltd stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
See More
Previous Close:
$0.627
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$25.84M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$3.83
Lakeshore Biopharma Co Ltd Stock (LSB) Company Profile
Name
Lakeshore Biopharma Co Ltd
Sector
Industry
Phone
-
Address
-
Compare LSB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LSB
Lakeshore Biopharma Co Ltd
|
0.00 | 25.84M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.20 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
750.58 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
845.72 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
394.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.30 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lakeshore Biopharma Co Ltd Stock (LSB) Latest News
Aug Ideas: Is LakeShore Biopharma Co Ltd stock gaining market shareJuly 2025 Summary & Long-Term Growth Plans - moha.gov.vn
What analysts say about LakeShore Biopharma Co Ltd Equity Warrant stockDividend Stock Watch & Superior Trading Portfolio - earlytimes.in
Can LakeShore Biopharma Co. Ltd stock sustain market leadershipQuarterly Portfolio Summary & Community Consensus Trade Alerts - Newser
Is LakeShore Biopharma Co. Ltd stock gaining market shareJuly 2025 Intraday Action & AI Driven Stock Movement Reports - Newser
What insider trading reveals about LakeShore Biopharma Co. Ltd stockMarket Trend Review & Verified Technical Signals - Newser
Will LakeShore Biopharma Co. Ltd (H6Z0) stock test record highs in 2025 - Newser
Why analysts recommend LakeShore Biopharma Co. Ltd (H6Z0) stockPortfolio Risk Report & Risk Adjusted Buy/Sell Alerts - Newser
Will LakeShore Biopharma Co. Ltd (H6Z0) stock see insider accumulationJuly 2025 Update & Breakout Confirmation Trade Signals - Newser
Is LakeShore Biopharma Co. Ltd (H6Z0) stock undervalued historicallyJuly 2025 PreEarnings & Low Risk High Reward Ideas - Newser
Will LakeShore Biopharma Co. Ltd (H6Z0) stock beat value stocksPortfolio Update Summary & Reliable Entry Point Trade Alerts - Newser
Will LakeShore Biopharma Co. Ltd (H6Z0) stock outperform foreign stocksEarnings Recap Summary & Growth Focused Stock Pick Reports - Newser
Analyst Downgrade: Will LakeShore Biopharma Co. Ltd stock outperform Dow Jones indexSell Signal & Consistent Profit Trade Alerts - moha.gov.vn
Why LakeShore Biopharma Co. Ltd Equity Warrant stock attracts high net worth investorsWeekly Gains Summary & Safe Entry Momentum Stock Tips - BỘ NỘI VỤ
What Analyst Watch Lists Suggest About KJMC Financial Services Limiteds MomentumBollinger Bands Signals & High-Risk, High-Reward? We Find the Winners - earlytimes.in
What Macro Risks Could Undermine Sylph Technologies Limiteds ForecastFundamental Strength Indicators & Exceptional Growth Portfolio - earlytimes.in
What drives LakeShore Biopharma Co Ltd stock priceStock Watchlist Updates & Affordable Portfolio Growth - earlytimes.in
Will LakeShore Biopharma Co. Ltd stock outperform Dow Jones index2025 Market Sentiment & Safe Investment Capital Preservation Plans - BỘ NỘI VỤ
EV Market: Will LakeShore Biopharma Co. Ltd Equity Warrant stock remain a Wall Street favoriteTrade Entry Report & Daily Growth Stock Investment Tips - moha.gov.vn
What analysts say about LakeShore Biopharma Co Ltd stockRetail Trading Trends & Rapid Capital Trading - earlytimes.in
Is LakeShore Biopharma Co. Ltd Equity Warrant stock trading at a premium valuationTrade Entry Report & AI Forecasted Entry/Exit Points - newser.com
Oceanpine Consortium to Acquire LakeShore Biopharma in US$37 Million Go-Private Transaction - globallegalchronicle.com
What sentiment indicators say about LakeShore Biopharma Co. Ltd stockJuly 2025 Reactions & Momentum Based Trading Ideas - newser.com
What insider purchases suggest about LakeShore Biopharma Co. Ltd (H6Z0) stock - newser.com
Will LakeShore Biopharma Co. Ltd Equity Warrant stock recover faster than peersPortfolio Risk Summary & Short-Term Swing Trade Alerts - newser.com
What the charts say about LakeShore Biopharma Co. Ltd todayJuly 2025 Spike Watch & Stepwise Trade Signal Implementation - newser.com
Is LakeShore Biopharma Co. Ltd stock a good choice for value investors2025 Top Decliners & Safe Swing Trade Setups - newser.com
Relative strength of LakeShore Biopharma Co. Ltd in sector analysisProduct Launch & Real-Time Stock Movement Alerts - newser.com
Is LakeShore Biopharma Co. Ltd (H6Z0) stock a buy for dividend portfolios2025 Top Decliners & Risk Controlled Daily Plans - newser.com
When is the best time to exit LakeShore Biopharma Co. LtdEarnings Risk Summary & Real-Time Chart Breakout Alerts - newser.com
Published on: 2025-11-19 13:43:49 - newser.com
Is LakeShore Biopharma Co. Ltd Equity Warrant stock safe for conservative investors2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com
Can LakeShore Biopharma Co. Ltd Equity Warrant stock sustain institutional interestEarnings Summary Report & Detailed Earnings Play Alerts - newser.com
Lakeshore Biopharma Co Ltd Stock (LSB) Financials Data
There is no financial data for Lakeshore Biopharma Co Ltd (LSB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.56%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):